Engineering the shikimate pathway for biosynthesis of molecules with pharmaceutical activities in E. coli

Current Opinion in Biotechnology

Volumn 42, Issue , 2016, Pages 1-6

  Jiang, Ming ^a   Zhang, Haoran ^b  

^a Shanghai Jiao Tong University   (China)

^b The State University of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BIOCHEMISTRY; BIOSYNTHESIS; ESCHERICHIA COLI; MICROORGANISMS; MOLECULES;

E. COLI; HIGH-EFFICIENCY; SHIKIMATE PATHWAY;

METABOLIC ENGINEERING;

4 HYDROXYCOUMARIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; COUMARIN; CYCLIC AMP; DEOXYVIOLACEIN; FLAVONOID; NARINGENIN; PHOSPHOTRANSFERASE; POLYPHENOL DERIVATIVE; PONCIRETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SAKURANETIN; SALICYLIC ACID; SALVIANIC ACID A; SHIKIMIC ACID; TETRAHYDROPAPAVEROLINE; UNCLASSIFIED DRUG; VIOLACEIN; DRUG;

BACTERIAL GENE; BACTERIAL STRAIN; BIOENGINEERING; BIOSYNTHESIS; ENZYME MECHANISM; ESCHERICHIA COLI; GENE CONTROL; GENE DELETION; GENE EXPRESSION; METABOLIC ENGINEERING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; TRANSCRIPTION REGULATION; CHEMISTRY; METABOLIC FLUX ANALYSIS; METABOLISM; PROCEDURES;

BIOSYNTHETIC PATHWAYS; ESCHERICHIA COLI; METABOLIC ENGINEERING; METABOLIC FLUX ANALYSIS; PHARMACEUTICAL PREPARATIONS; SHIKIMIC ACID;

EID: 84958969892     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2016.01.016     Document Type: Review

References (50)

1. Fox D.T., Hotta K., Kim C.Y., Koppisch A.T. The missing link in petrobactin biosynthesis: asbF encodes a (-)-3-dehydroshikimate dehydratase. Biochemistry 2008, 47:12251-12253.
2. Mitsuhashi S., Davis B.D. Aromatic biosynthesis, XIII. Conversion of quinic acid to 5-dehydroquinic acid by quinic dehydrogenase. Biochim Biophys Acta 1954, 15:268-280.
3. Herrmann K.M., Weaver L.M. The shikimate pathway. Annu Rev Plant Physiol Plant Mol Biol 1999, 50:473-503.
4. Oldiges M., Kunze M., Degenring D., Sprenger G.A., Takors R. Stimulation, monitoring, and analysis of pathway dynamics by metabolic profiling in the aromatic amino acid pathway. Biotechnol Prog 2004, 20:1623-1633.
5. Pittard J., Camakaris H., Yang J. The TyrR regulon. Mol Microbiol 2005, 55:16-26.
6. Yamamoto K., Ishihama A. Characterization of copper-inducible promoters regulated by CpxA/CpxR in Escherichia coli. Biosci Biotechnol Biochem 2006, 70:1688-1695.
7. Man T.K., Pease A.J., Winkler M.E. Maximization of transcription of the serC (pdxF)-aroA multifunctional operon by antagonistic effects of the cyclic AMP (cAMP) receptor protein-cAMP complex and Lrp global regulators of Escherichia coli K-12. J Bacteriol 1997, 179:3458-3469.
8. Tatarko M., Romeo T. Disruption of a global regulatory gene to enhance central carbon flux into phenylalanine biosynthesis in Escherichia coli. Curr Microbiol 2001, 43:26-32.
9. Knop D.R., Draths K.M., Chandran S.S., Barker J.L., von Daeniken R., Weber W., Frost J.W. Hydroaromatic equilibration during biosynthesis of shikimic acid. J Am Chem Soc 2001, 123:10173-10182.
10. Yi J., Draths K.M., Li K., Frost J.W. Altered glucose transport and shikimate pathway product yields in E. coli. Biotechnol Prog 2003, 19:1450-1459.
11. Yi J., Li K., Draths K.M., Frost J.W. Modulation of phosphoenolpyruvate synthase expression increases shikimate pathway product yields in E. coli. Biotechnol Prog 2002, 18:1141-1148.
12. Stincone A., Prigione A., Cramer T., Wamelink M.M., Campbell K., Cheung E., Olin-Sandoval V., Gruning N., Kruger A., Tauqeer Alam M., et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc 2014.
13. Patnaik R., Liao J.C. Engineering of Escherichia coli central metabolism for aromatic metabolite production with near theoretical yield. Appl Environ Microbiol 1994, 60:3903-3908.
14. Patnaik R., Spitzer R.G., Liao J.C. Pathway engineering for production of aromatics in Escherichia coli: confirmation of stoichiometric analysis by independent modulation of AroG, TktA, and Pps activities. Biotechnol Bioeng 1995, 46:361-370.
15. Varma A., Boesch B.W., Palsson B.O. Biochemical production capabilities of Escherichia coli. Biotechnol Bioeng 1993, 42:59-73.
16. Ran N., Draths K.M., Frost J.W. Creation of a shikimate pathway variant. J Am Chem Soc 2004, 126:6856-6857.
17. Khamduang M., Packdibamrung K., Chutmanop J., Chisti Y., Srinophakun P. Production of l-phenylalanine from glycerol by a recombinant Escherichia coli. J Ind Microbiol Biotechnol 2009, 36:1267-1274.
18. Ahn J.O., Lee H.W., Saha R., Park M.S., Jung J.K., Lee D.Y. Exploring the effects of carbon sources on the metabolic capacity for shikimic acid production in Escherichia coli using in silico metabolic predictions. J Microbiol Biotechnol 2008, 18:1773-1784.
19. Jossek R., Bongaerts J., Sprenger G.A. Characterization of a new feedback-resistant 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase AroF of Escherichia coli. FEMS Microbiol Lett 2001, 202:145-148.
20. Kikuchi Y., Tsujimoto K., Kurahashi O. Mutational analysis of the feedback sites of phenylalanine-sensitive 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase of Escherichia coli. Appl Environ Microbiol 1997, 63:761-762.
21. Ger Y.M., Chen S.L., Chiang H.J., Shiuan D. A single Ser-180 mutation desensitizes feedback inhibition of the phenylalanine-sensitive 3-deoxy-d-arabino-heptulosonate 7-phosphate (DAHP) synthetase in Escherichia coli. J Biochem 1994, 116:986-990.
22. Ray J.M., Yanofsky C., Bauerle R. Mutational analysis of the catalytic and feedback sites of the tryptophan-sensitive 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase of Escherichia coli. J Bacteriol 1988, 170:5500-5506.
23. Lutke-Eversloh T., Stephanopoulos G. l-Tyrosine production by deregulated strains of Escherichia coli. Appl Microbiol Biotechnol 2007, 75:103-110.
24. Santos C.N., Xiao W., Stephanopoulos G. Rational, combinatorial, and genomic approaches for engineering l-tyrosine production in Escherichia coli. Proc Natl Acad Sci U S A 2012, 109:13538-13543.
25. McKee A.E., Rutherford B.J., Chivian D.C., Baidoo E.K., Juminaga D., Kuo D., Benke P.I., Dietrich J.A., Ma S.M., Arkin A.P., et al. Manipulation of the carbon storage regulator system for metabolite remodeling and biofuel production in Escherichia coli. Microb Cell Fact 2012, 11:79.
26. Berry A. Improving production of aromatic compounds in Escherichia coli by metabolic engineering. Trends Biotechnol 1996, 14:250-256.
27. Bongaerts J., Kramer M., Muller U., Raeven L., Wubbolts M. Metabolic engineering for microbial production of aromatic amino acids and derived compounds. Metab Eng 2001, 3:289-300.
28. Rodriguez A., Martinez J.A., Flores N., Escalante A., Gosset G., Bolivar F. Engineering Escherichia coli to overproduce aromatic amino acids and derived compounds. Microb Cell Fact 2014, 13:126.
29. Vane J.R., Botting R.M. The mechanism of action of aspirin. Thromb Res 2003, 110:255-258.
30. Ahmadi M.K., Fawaz S., Jones C.H., Zhang G., Pfeifer B.A. Total biosynthesis and diverse applications of the nonribosomal peptide-polyketide siderophore yersiniabactin. Appl Environ Microbiol 2015, 81:5290-5298.
31. Lin Y., Sun X., Yuan Q., Yan Y. Extending shikimate pathway for the production of muconic acid and its precursor salicylic acid in Escherichia coli. Metab Eng 2014, 23:62-69.
32. Noda S., Shiraia T., Oyamaa S., Kondo A. Metabolic design of a platform Escherichia coli strain producing various chorismate derivatives. Metab Eng 2015, in press. 10.1016/j.ymben.2015.11.007.
33. Kittakoop P., Mahidol C., Ruchirawat S. Alkaloids as important scaffolds in therapeutic drugs for the treatments of cancer, tuberculosis, and smoking cessation. Curr Top Med Chem 2014, 14:239-252.
34. Cushnie T.P., Cushnie B., Lamb A.J. Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities. Int J Antimicrob Agents 2014, 44:377-386.
35. Nakagawa A., Minami H., Kim J.S., Koyanagi T., Katayama T., Sato F., Kumagai H. A bacterial platform for fermentative production of plant alkaloids. Nat Commun 2011, 2:326.
36. Nakagawa A., Matsuzaki C., Matsumura E., Koyanagi T., Katayama T., Yamamoto K., Sato F., Kumagai H., Minami H. (R,S)-tetrahydropapaveroline production by stepwise fermentation using engineered Escherichia coli. Sci Rep 2014, 4:6695.
37. Woo H.D., Kim J. Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis. PLOS ONE 2013, 8:e75604.
38. Izzi V., Masuelli L., Tresoldi I., Sacchetti P., Modesti A., Galvano F., Bei R. The effects of dietary flavonoids on the regulation of redox inflammatory networks. Front Biosci (Landmark Ed) 2012, 17:2396-2418.
39. Kim M.J., Kim B.G., Ahn J.H. Biosynthesis of bioactive O-methylated flavonoids in Escherichia coli. Appl Microbiol Biotechnol 2013, 97:7195-7204.
40. Wu J., Du G., Zhou J., Chen J. Metabolic engineering of Escherichia coli for (2S)-pinocembrin production from glucose by a modular metabolic strategy. Metab Eng 2013, 16:48-55.
41. Santos C.N., Koffas M., Stephanopoulos G. Optimization of a heterologous pathway for the production of flavonoids from glucose. Metab Eng 2011, 13:392-400.
42. Musa M.A., Cooperwood J.S., Khan M.O. A review of coumarin derivatives in pharmacotherapy of breast cancer. Curr Med Chem 2008, 15:2664-2679.
43. Thornes R.D., Daly L., Lynch G., Breslin B., Browne H., Browne H.Y., Corrigan T., Daly P., Edwards G., Gaffney E., et al. Treatment with coumarin to prevent or delay recurrence of malignant melanoma. J Cancer Res Clin Oncol 1994, 120(Suppl):S32-S34.
44. Lin Y., Sun X., Yuan Q., Yan Y. Combinatorial biosynthesis of plant-specific coumarins in bacteria. Metab Eng 2013, 18:69-77.
45. Lin Y., Shen X., Yuan Q., Yan Y. Microbial biosynthesis of the anticoagulant precursor 4-hydroxycoumarin. Nat Commun 2013, 4:2603.
46. Rodrigues A.L., Trachtmann N., Becker J., Lohanatha A.F., Blotenberg J., Bolten C.J., Korneli C., de Souza Lima A.O., Porto L.M., Sprenger G.A., et al. Systems metabolic engineering of Escherichia coli for production of the antitumor drugs violacein and deoxyviolacein. Metab Eng 2013, 20:29-41.
47. Rodrigues A.L., Becker J., de Souza Lima A.O., Porto L.M., Wittmann C. Systems metabolic engineering of Escherichia coli for gram scale production of the antitumor drug deoxyviolacein from glycerol. Biotechnol Bioeng 2014, 111:2280-2289.
48. Wang X.J., Xu J.X. Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. Neurosci Res 2005, 51:129-138.
49. Oh K.S., Oh B.K., Mun J., Seo H.W., Lee B.H. Salvianolic acid A suppress lipopolysaccharide-induced NF-kappaB signaling pathway by targeting IKKbeta. Int Immunopharmacol 2011, 11:1901-1906.
50. Yao Y.F., Wang C.S., Qiao J., Zhao G.R. Metabolic engineering of Escherichia coli for production of salvianic acid A via an artificial biosynthetic pathway. Metab Eng 2013, 19:79-87.